Cargando…
Dravet syndrome
"Dravet syndrome" (DS) previously named severe myoclonic epilepsy of infancy (SMEI), or epilepsy with polymorphic seizures, is a rare disorder characterized by an early, severe, generalized, epileptic encephalopathy. DS is characterized by febrile and afebrile seizures beginning in the 1st...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2745418/ https://www.ncbi.nlm.nih.gov/pubmed/19737414 http://dx.doi.org/10.1186/1824-7288-35-27 |
_version_ | 1782171963612987392 |
---|---|
author | Incorpora, Gemma |
author_facet | Incorpora, Gemma |
author_sort | Incorpora, Gemma |
collection | PubMed |
description | "Dravet syndrome" (DS) previously named severe myoclonic epilepsy of infancy (SMEI), or epilepsy with polymorphic seizures, is a rare disorder characterized by an early, severe, generalized, epileptic encephalopathy. DS is characterized by febrile and afebrile seizures beginning in the 1st year of life followed by different types of seizures (either focal or generalized), which are typically resistant to antiepileptic drugs. A developmental delay from the 2nd to 3rd year of life becomes evident, together with motor disturbances and personality disorders. Beside the classic syndrome, there are milder cases which have been called severe myoclonic epilepsy borderline (SMEB). DS is caused by a mutation in the neuronal sodium channel gene, SCN1A , that is also mutated in generalized epilepsy with FS+ (GEFS+). |
format | Text |
id | pubmed-2745418 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-27454182009-09-17 Dravet syndrome Incorpora, Gemma Ital J Pediatr Review "Dravet syndrome" (DS) previously named severe myoclonic epilepsy of infancy (SMEI), or epilepsy with polymorphic seizures, is a rare disorder characterized by an early, severe, generalized, epileptic encephalopathy. DS is characterized by febrile and afebrile seizures beginning in the 1st year of life followed by different types of seizures (either focal or generalized), which are typically resistant to antiepileptic drugs. A developmental delay from the 2nd to 3rd year of life becomes evident, together with motor disturbances and personality disorders. Beside the classic syndrome, there are milder cases which have been called severe myoclonic epilepsy borderline (SMEB). DS is caused by a mutation in the neuronal sodium channel gene, SCN1A , that is also mutated in generalized epilepsy with FS+ (GEFS+). BioMed Central 2009-09-08 /pmc/articles/PMC2745418/ /pubmed/19737414 http://dx.doi.org/10.1186/1824-7288-35-27 Text en Copyright © 2009 Incorpora; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Incorpora, Gemma Dravet syndrome |
title | Dravet syndrome |
title_full | Dravet syndrome |
title_fullStr | Dravet syndrome |
title_full_unstemmed | Dravet syndrome |
title_short | Dravet syndrome |
title_sort | dravet syndrome |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2745418/ https://www.ncbi.nlm.nih.gov/pubmed/19737414 http://dx.doi.org/10.1186/1824-7288-35-27 |
work_keys_str_mv | AT incorporagemma dravetsyndrome |